OFweek Medical Technology Network April 7 news, the world's leading provider of life sciences research cloud solutions provider Medidata today announced the strengthening of cooperation with Peking University Clinical Research Institute (PUCRI), which is focused on improving China's high-quality clinical trials and A world-renowned academic research center for medical innovation. With the extensive network, expertise and resources of the Peking University Clinical Research Institute in clinical development, the collaboration will promote the use of Medidata Clinical Cloud in China to optimize local drug development by improving the efficiency and speed of clinical trials.
Professor Fang Weigang, deputy director of the Peking University School of Medicine and director of the Peking University Clinical Research Institute, said: "We are very pleased to strengthen our partnership with Medidata. The clinical trials of most local companies in China are still based on a paper model. We hope to work with Medidata. A bridge between the world's leading technology and innovative drug development to further enhance clinical development in China."
Professor Wu Yangfeng, executive deputy director of the Peking University Clinical Research Institute, said: "The deepening cooperation between Peking University Clinical Research Institute and Medidata will provide better services and new vitality for the development of new drugs in China."
Combining cutting-edge cloud solutions with extensive experience in clinical development, Medidata has worked with Peking University Clinical Research Institute for many years to bring innovative technology to China's clinical research. Together, they will help life sciences companies improve operational efficiency and increase the productivity of clinical trial programs in China. Through deepening cooperation, Medidata and Peking University Research Institute will bring more industry-leading technologies to life science companies in China, simplify clinical trials and ultimately help patients get new treatments faster.
Mr. Takeru Yamamoto, Managing Director of Medidata Asia Pacific, said: "I am honored to work more closely with Peking University Clinical Research Institute to bring our globally recognized cloud technology to China. Using the Institute's expertise in clinical trials, We will be able to help more life sciences institutions in China accelerate drug development, helping patients get the latest treatments in both local and global markets."
Signing ceremony site
We're professional uterine manipulator manufacturers and suppliers in China, specialized in providing high quality medical instruments with reasonable price. We warmly welcome you to buy or wholesale bulk uterine manipulator for sale here and get quotation from our factory.
Uterine Manipulator,Gynecology Uterine Manipulator,Uterine Manipulator Instrument,Laparoscopic Uterine Manipulator
Tonglu WANHE Medical Instrument Co., Ltd , https://www.vanhurhealth.com